MannKind Corporation Reports 2015 Second Quarter Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to MannKind Corporation Reports 2015 Second Quarter Financial Results

MannKind (MNKD) Appoints New Chief Medical Officer

August 10, 2015 9:16 AM EDT

MannKind (NASDAQ: MNKD) announced the appointment of Dr. Raymond Urbanski as its Chief Medical Officer. As Chief Medical Officer, Dr. Urbanski will lead MannKind's overall drug development activities and will be a member of the Executive Leadership Team.

"Dr.... More

MannKind (MNKD) Tops Q2 EPS by 1c

August 10, 2015 8:01 AM EDT

MannKind (NASDAQ: MNKD) reported Q2 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08).

Cash and cash equivalents were $107.2 million at June 30, 2015, compared to $120.8 million in the first quarter of 2015. During the second quarter of 2015, we received $6.7 million in proceeds from warrant and option... More